Latest news
AbCellera (NASDAQ:ABCL) Shares Surge Ahead of Monday's ABCL635 Phase 2 Trial Results - TechStock²TechStock² · Sat, 08 Aug 2026 14:45:00 GMTRecursion Pharmaceuticals (NASDAQ:RXRX) Cut to "Strong Sell" at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:29:09 GMTRecursion Pharmaceuticals (RXRX) Reported Q2 Revenue Pressure, Is The Valuation Gap Too Wide? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 05:45:46 GMTRecursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 - MoomooMoomoo · Sat, 08 Aug 2026 00:33:02 GMTRecursion Pharmaceuticals Inc (RXRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 15:03:51 GMTRecursion Pharmaceuticals | SCHEDULE 13G: Others - MoomooMoomoo · Fri, 07 Aug 2026 14:49:17 GMTAI Drug Discovery Stocks Face Numerous Threats - NanalyzeNanalyze · Fri, 07 Aug 2026 13:53:41 GMTRecursion Pharmaceuticals (RXRX) Director Blake Borgeson Sells 3 - GuruFocusGuruFocus · Fri, 07 Aug 2026 07:50:49 GMT